Results 161 to 170 of about 147,625 (256)
Targeting Fibroblast Foxc2 Promotes Neurovascular Recovery by Suppressing Sdc4 After Ischemic Stroke
YZD‐27, a Tanshinone IIA derivative, remains effective up to 24 h after ischemic stroke, reducing infarct volume and restoring motor and cognitive function. Single‐cell analysis identifies fibroblasts as a central signaling hub, where YZD‐27 binds Foxc2 to repress Sdc4 and attenuate Sdc4/Fn1‐mediated endothelial–fibroblast communication, promoting ...
Yixin Jiang +10 more
wiley +1 more source
Chlorinated paraffins (CPs) disrupt mitochondrial redox homeostasis, causing oxidative stress and gut‐liver axis dysfunction that ultimately drives lipid metabolic disorders. Inspired by natural Mn‐SOD, we developed oxygen‐bridged MIL‐100(Mn) nanozymes with enhanced SOD/CAT‐like cascade activity. Oral administration restored CP‐induced lipid metabolism
Qi Zhang +12 more
wiley +1 more source
Prevalence of methicillin-resistant Staphylococcus aureus carriers in dental care staff: A systematic review and meta-analysis [PDF]
Sánchez-Villamil JP +2 more
europepmc +1 more source
The senolytic hydrogel (ABT@Gal‐gel) was engineered using an injectable bacterial cellulose (BC)/chitosan‐based hydrogel that encapsulates galactose‐modified polydopamine nanoparticles loaded with ABT‐263, a selective BCL2 inhibitor. The postoperative injection of the hydrogel enabled β‐galactosidase‐responsive release of ABT‐263 to eliminate ...
Like Ning +13 more
wiley +1 more source
Ovatodiolide directly targets NME1 to restore BRAT1–ATM‐dependent DNA damage repair signaling in diabetic kidney disease. By disrupting TRIM47‐mediated NME1 ubiquitination and degradation, ovatodiolide stabilizes NME1, promotes tubular DNA repair, and alleviates renal injury and fibrosis, supporting NME1 stabilization as a potential therapeutic ...
Yihao Long +13 more
wiley +1 more source
[Flagellate erythema secondary to bleomycin: case report with favorable outcome]. [PDF]
Leal-León R +4 more
europepmc +1 more source
ABSTRACT Pirtobrutinib, a highly selective, non‐covalent Bruton tyrosine kinase inhibitor (BTKi) previously demonstrated durable efficacy and tolerable safety following covalent (c) BTKi therapy in heavily pretreated relapsed/refractory (R/R) mantle cell lymphoma (MCL).
Michael L. Wang +36 more
wiley +1 more source
[Classic presentation of neuromyelitis optica: clinical case and review of the literature]. [PDF]
Núñez-Martínez FJ +5 more
europepmc +1 more source
ABSTRACT Autoinflammatory disorders (AIDs) are a clinically heterogeneous group of inborn errors of immunity primarily caused by dysregulation in the innate immune system. Clinical diagnosis is often challenging due to clinical heterogeneity and the overlapping phenotypes with other inborn errors of immunity and monogenic conditions that mimic AIDs ...
Vaishnavi Ashok Badiger +28 more
wiley +1 more source
Drug-related jaw osteonecrosis: a 6-year retrospective study from two centers in Argentina. [PDF]
Leonardi N +4 more
europepmc +1 more source

